ADCR Consortium

Granted ADCR Authorisations in EU and in GB/UK

All submitted ADCR dossiers, to ECHA in the EU, and to HSE in the UK have been granted 12 year authorisation review periods from the European Commission and Defra in the UK.

ADCR have collated the status of all authorisation decisions with links to the decisions and additional information. The collected information also provides information on dossiers that have been submitted and that are still undergoing the assessment by the authorities.

The information is found in the ADCR Communication ‘Summary of ADCR applications submitted in EU and GB and decisions status’ (pdf, version 24 February 2026).

Update 3 February 2026

In EU, ECHA informed applicants in January 2026 that they are suspending processing of chromates applications. For all Review Reports submitted by ADCR, the use can continue under transitional measures according to REACH Article 61.1, until the future Cr(VI) restriction enters into force, or until the European Commission makes a different decision.

For more information on the Cr(VI) process, please see European Commission Q&A document 'Towards a restriction of Cr(VI) substances under REACH (version 25 August, 2025) and ECHA Restrictions under Consideration.

The first three UK decisions for Tranche 2 were adopted by Defra in January 2026 and the final decisions are expected in March 2026. Transitional measures, according to UK REACH Article 61.1 are in place for the submitted review reports, thus the uses covered by the review reports can continue until Defra has made its decisions (see Summary document linked above).